GLYPHIC BIOTECHNOLOGIES
We sequence proteins. Glyphic Biotechnologies is a biotechnology startup revolutionizing the field of proteomics. While DNA can reveal biological insights, proteins actually tell us what our bodies will do. We are developing a first-of-its-kind, next-generation protein sequencing platform to enable researchers to gain novel insights into biology and disease.
GLYPHIC BIOTECHNOLOGIES
Industry:
Biotechnology Life Science
Founded:
2021-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.glyphic.bio
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
9.37 M USD
Technology used in webpage:
Google Apps For Business Microsoft Azure DNS Accelerated Mobile Pages
Similar Organizations
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
Catena Biosciences
Biotech company focused on protein conjugation.
Mana Therapeutics
Next-Generation Immunotherapies
Menten AI
Menten AI develops peptide and protein therapeutics using machine learning and quantum computing.
Novellus
Novellus is a biotechnology company working to develop engineered cellular medicines.
Quantum SI
Quantum SI offers Next Generation Protein Sequencing that makes diagnostics digital.
Tierra Biosciences
Tierra Biosciences is a synthetic biology company that offers an AI-driven platform with a vast range of custom proteins for research.
Current Advisors List
Current Employees Featured
Founder
Investors List
National Institutes of Health
National Institutes of Health investment in Grant - Glyphic Biotechnologies
New York State’s Empire State Development Fund
New York State’s Empire State Development Fund investment in Grant - Glyphic Biotechnologies
Qiagen
Qiagen investment in Grant - Glyphic Biotechnologies
Johnson & Johnson Innovation
Johnson & Johnson Innovation investment in Grant - Glyphic Biotechnologies
Artis Ventures (AV)
Artis Ventures (AV) investment in Seed Round - Glyphic Biotechnologies
OUP (Osage University Partners)
OUP (Osage University Partners) investment in Seed Round - Glyphic Biotechnologies
Axial VC
Axial VC investment in Seed Round - Glyphic Biotechnologies
Wing Venture Capital
Wing Venture Capital investment in Seed Round - Glyphic Biotechnologies
Civilization Ventures
Civilization Ventures investment in Seed Round - Glyphic Biotechnologies
OMX Ventures
OMX Ventures investment in Seed Round - Glyphic Biotechnologies
Official Site Inspections
http://www.glyphic.bio Semrush global rank: 5.54 M Semrush visits lastest month: 1.53 K
- Host name: 192.0.78.155
- IP address: 192.0.78.155
- Location: San Francisco United States
- Latitude: 37.7506
- Longitude: -122.4121
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94110
More informations about "Glyphic Biotechnologies"
Glyphic Biotechnologies - Crunchbase Company Profile …
Organization. Glyphic Biotechnologies . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. …See details»
Glyphic Biotechnologies Company Profile 2024: …
Www.glyphic.bio. Ownership Status. Privately Held (backing) Financing Status. Venture Capital-Backed. Corporate Office. 169 Madison Avenue; Suite 2216; …See details»
glyphicbio – Glyphic Biotechnologies
Glyphic Biotechnologies is 1 of 25 winners in the Falling Walls Venture 2021 competition and will be competing in Berlin for Science Startup Breakthrough of the Year. ... today announced the ten companies selected to participate in the …See details»
Glyphic Biotechnologies - LinkedIn
Glyphic Biotechnologies is a biotechnology startup revolutionizing the field of proteomics. While DNA can reveal biological insights, proteins actually tell us what our bodies will do. Skip to ...See details»
Glyphic Biotechnologies | Information, Portfolio & Contact | Finallot
Glyphic Bio. founded date. 01.01.2021. Number of employees. 11-50. Company Type. For Profit. Last funding type. Venture - Series Unknown. IPO status. Private. Description. The company …See details»
Glyphic Biotechnologies | Seed - National Institutes of Health
Glyphic Biotechnologies is developing a single-molecule, massively parallel protein sequencing platform that does not rely on the existing, decades-old technologies of ELISA and mass …See details»
Glyphic Biotechnologies - Company Profile - Tracxn
Sep 7, 2024 Glyphic Biotechnologies ranks 10th among 177 active competitors. 41 of its competitors are funded while 21 have exited. Overall, Glyphic Biotechnologies and its …See details»
Glyphic Biotechnologies - VentureRadar
" Glyphic Biotechnologies is decoding the human proteome through full coverage, de novo protein sequencing at single molecule resolutions, advancing beyond the decades old technologies …See details»
Glyphic Biotechnologies - Overview, News & Similar companies
Who is Glyphic Biotechnologies. Glyphic Biotechnologies is a biotechnology company revolutionizing the field of proteomics. While DNA can reveal biological insights, proteins actu …See details»
Glyphic Biotechnologies - Harpoon Ventures
Glyphic Bio is transforming the field of proteomics by making it possible to sequence all 20 amino acids with single-molecule precision. While DNA sequencing revolutionized biomedical …See details»
Glyphic Biotechnologies - Craft
Glyphic Biotechnologies has 5 employees at their 1 location and $6.03 m in total funding,. See insights on Glyphic Biotechnologies including office locations, competitors, revenue, financials, …See details»
The dawn of a revolutionary platform | Sensu.health
The platform that Glyphic is constructing is in alignment with a broader industry shift, as proteomics continues to gain prominence alongside genomics and transcriptomics. This is an …See details»
Founder Spotlight #40: Josh Yang @ Glyphic Biotechnologies
May 10, 2022 Glyphic Bio is a proteomics platform company enabling the development of novel therapeutics, diagnostics, and ultimately, a deeper understanding of human biology. Although …See details»
Glyphic Biotechnologies - Products, Competitors, Financials, …
QIAGEN supports young biotechnology and pharma companies by announcing winners of first-ever annual Biotech Grants — RheumaGen. Apr 17, 2024. Germantown, Maryland, and …See details»
Glyphic Bio: Decoding Human Proteome with Single Cell Protein …
April 12, 2024 Repost from Berkeley Bakar Labs -- As a PhD candidate, Glyphic Bio co-founder and CTO Daniel Estandian was puzzled. He saw a clear divide between areas researchers …See details»
Glyphic Biotechnologies Recognized as 1 of 10
Jul 29, 2021 Glyphic Biotechnologies Recognized as 1 of 10 Best-in-Class Life Science Tools Startups in the BioTools Innovator Accelerator Cohort BioTools Innovator , a new program …See details»
Glyphic Biotechnologies – Startups.Bio
Apr 27, 2022 Glyphic Biotechnologies is an MIT spin-out aiming to accelerate the critical but slow step of sequencing new proteins, potentially cutting drug development times down by …See details»
Speaker Joshua Yang - QIAGEN
Josh is the co-founder and CEO of Glyphic Biotechnologies, a VC-funded biotechnology startup commercializing a next-generation protein sequencing platform. His first-author, peer-reviewed …See details»
LongeVC Backs Glyphic Bio to Back Next-Gen Protein Sequencing
Nov 21, 2024 Glyphic Bio’s technology not only has strong potential within proteomics—a market poised for substantial growth—but also holds applications across other rapidly evolving …See details»
Organoid bioprinting: from cells to functional tissues
6 days ago The biofabrication of complex human tissues to recapitulate organ-specific architecture and function requires a combination of engineering control and intrinsic self …See details»